PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33998863-7	2021	Materials and Methods: We used whole-body plethysmography to assess the impact of the CB2 cannabinoid agonist LY2828360 on fentanyl-induced respiratory depression using wild-type (WT) and CB2 knockout (CB2KO) mice.	Fentanyl	123-131	cannabinoid receptor 2 (macrophage)	Mus musculus	86-89	
33998863-8	2021	Results: Fentanyl reduced minute ventilation and respiratory frequency without altering tidal volume in both WT and CB2KO mice.	Fentanyl	9-17	cannabinoid receptor 2 (macrophage)	Mus musculus	116-119	
33998863-20	2021	Our findings suggest that the CB2 cannabinoid agonist LY2828360 may provide CB2-mediated protection against fentanyl-induced respiratory depression, a detrimental and unwanted side effect of opioid use and abuse.	Fentanyl	108-116	cannabinoid receptor 2 (macrophage)	Mus musculus	30-33	
33998863-20	2021	Our findings suggest that the CB2 cannabinoid agonist LY2828360 may provide CB2-mediated protection against fentanyl-induced respiratory depression, a detrimental and unwanted side effect of opioid use and abuse.	Fentanyl	108-116	cannabinoid receptor 2 (macrophage)	Mus musculus	76-79